Abstract
Diagnosis and classification are two essential points for correct patient management. Correct classification allows proper treatment and alerts of the risk of leprosy reaction and nerve damage. The Ridley–Jopling classification recognizes the complex pathogenesis of leprosy and is based on a spectrum that extends from tuberculoid leprosy (TT), through borderline tuberculoid (BT), mid-borderline (BB), borderline lepromatous (BL), to the poorly resistant lepromatous leprosy (LL). The World Health Organization (WHO) classification, for therapeutic purposes, divides patients into paucibacillary (PB) and multibacillary (MB) on the basis of the number of skin lesions. PB cases have up to five skin lesions in total, whereas MB cases have six or more skin lesions. The two systems are complementary rather than exclusive.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ridley DS. Pathogenesis of leprosy and related diseases. London: Wright; 1988.
Ridley DS, Jopling WH. A classification of leprosy for research purposes. Lepr Rev. 1962;33:119–28.
Ridley DS, Jopling WH. Classification of leprosy according to immunity—a five-group system. Int J Lepr Other Mycobact Dis. 1966;34:255–73.
Ridley DS. Nature of the leprosy spectrum. In: Ridley DS, editor. Pathogenesis of leprosy and related diseases. London: Wright; 1988. p. 93–105.
Noto S, Clapasson A, Nunzi E. Classification of leprosy: the mystery of “reactional tuberculoid”. G Ital Dermatol Venereal. 2007;142:294–5.
WHO. Chemotherapy of leprosy for control programmes. Technical report series 675. Geneva: World Health Organization; 1982.
WHO. A guide to leprosy control. 2nd ed. Geneva: WHO; 1988.
WHO. Enhanced global strategy for further reducing the disease burden due to leprosy (2011–2015). Operational guidelines (Updated); 2009
Lockwood DN, Sarno E, Smith WC. Classifying leprosy patients–searching for the perfect solution? Lepr Rev. 2007;78:317–20.
Guia para o controle da hanseniase. Brasilia: Ministério da Saúde; 2002. http://bvsms. saude.gov.br/bvs/publicacoes/guia_de_hanseniase.pdf.
Talhari S. Diagnosis, classification and prognosis. Int J Leprosy. 1996;64(Suppl):s13–4.
Parkash O. Classification of leprosy into multibacillary and paucibacillary groups: an analysis. FEMS Immunol Med Microbiol. 2009;55:1–5.
Buhrer-Sekula S, Visschedijk J, Grossi MAF, et al. The ML flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients. Lepr Rev. 2007;78:271–9.
WHO. Guidelines for the diagnosis, treatment and prevention of leprosy; 2018.
Alemu Belachew W, Naafs B. Position statement: leprosy: diagnosis, treatment and follow-up. J Eur Acad Dermatol Venereol. 2019;33(7):1205–13.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Massone, C., Brunasso, A.M.G. (2022). Classification of Leprosy. In: Nunzi, E., Massone, C., Portaels, F. (eds) Leprosy and Buruli Ulcer. Springer, Cham. https://doi.org/10.1007/978-3-030-89704-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-89704-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-89703-1
Online ISBN: 978-3-030-89704-8
eBook Packages: MedicineMedicine (R0)